Wealth Quarterback LLC

Position in NVO — Novo Nordisk A S

CIK 1803386 TOMS RIVER, NJ

Position in NVO

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$892,930

+$227,498 QoQ

Shares Held

18,626

+2.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#551

of 1,348 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Wealth Quarterback LLC holds $7,847,504 across 9 Drug Manufacturers - General names. NVO ranks #4 (11.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,506	$1,806,341
2	JNJ	Johnson & Johnson	6,974	$1,771,186
3	BMY	Bristol Myers Squibb Co	26,938	$1,552,167
4	NVO	Novo Nordisk A S This page	18,626	$892,930
5	AMGN	Amgen Inc	1,763	$638,417
6	MRK	Merck & Co., Inc.	2,856	$366,996
7	ABBV	AbbVie Inc.	1,261	$317,318
8	GILD	Gilead Sciences, Inc.	2,244	$283,506

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$892,930	18,626	+2.9%	Shares	Sole	2026-07-27
2026-03-31	$665,432	18,107	+14.5%	Shares	Sole	2026-04-09
2025-12-31	$804,361	15,809	-22.6%	Shares	Sole	2026-01-15
2025-09-30	$1,132,772	20,414	+3.0%	Shares	Sole	2025-10-20
2025-06-30	$1,367,700	19,816	+23.7%	Shares	Sole	2025-08-08
2025-03-31	$1,112,498	16,021	+29.6%	Shares	Sole	2025-05-05
2024-12-31	$1,063,293	12,361	+72.0%	Shares	Sole	2025-01-31
2024-09-30	$855,756	7,187	+1455.6%	Shares	Sole	2024-11-01
2021-09-30	$44,356	462	+40.0%	Shares	Sole	2021-11-17
2021-06-30	$27,644	330	+2.5%	Shares	Sole	2021-08-11
2020-03-31	$19,384	322	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.